Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040099

« Back to Dashboard

NDA 040099 describes NORCO, which is a drug marketed by Apil and is included in two NDAs. It is available from sixteen suppliers. Additional details are available on the NORCO profile page.

The generic ingredient in NORCO is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for 040099
Ingredient:acetaminophen; hydrocodone bitartrate
Formulation / Manufacturing:see details
Pharmacology for NDA: 040099
Mechanism of ActionOpioid Agonists
Suppliers and Packaging for NDA: 040099
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORCO acetaminophen; hydrocodone bitartrate TABLET;ORAL 040099 ANDA Allergan, Inc. 0023-6002 0023-6002-01 100 TABLET in 1 BOTTLE, PLASTIC (0023-6002-01)
NORCO acetaminophen; hydrocodone bitartrate TABLET;ORAL 040099 ANDA Actavis Pharma, Inc. 0591-3202 0591-3202-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-3202-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;5MG
Approval Date:Jun 25, 1997TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.